Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists track patients years after pioneering HIV gene treatment

NCT ID NCT02390297

Summary

This study is checking for any long-term safety problems in people who previously received an experimental gene therapy for HIV. The therapy involved modifying a person's own blood cells to help them fight the virus. Researchers are following 11 participants to see if any delayed side effects appear years after the treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Quest Clinical Research

    San Francisco, California, 94115, United States

  • UCLA CARE Center

    Los Angeles, California, 90035, United States

Conditions

Explore the condition pages connected to this study.